Publication Name	World Journal of Gastroenterology
Manuscript ID	18384
Country	Spain

Received	2015-04-19 10:18
Peer-Review Started	2015-04-20 14:14
To Make the First Decision	2015-06-23 14:52
Return for Revision	2015-06-26 14:07
Revised	2015-07-04 03:31
Second Decision	2015-09-12 21:58
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2015-09-14 11:16
Articles in Press	2015-09-14 11:16
Publication Fee Transferred
Edit the Manuscript by Language Editor	2015-09-28 09:43
Typeset the Manuscript	2015-10-21 09:56
Publish the Manuscript Online	2015-11-11 13:34

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Transplantation
Manuscript Type	Topic Highlights
Article Title	Management of hepatitis B virus infection after liver transplantation
Manuscript Source	Invited Manuscript
All Author List	Miguel Jiménez-Pérez, Rocío González-Grande, José Mostazo Torres, Carolina González Arjona and Francisco Javier Rando-Muñoz
Funding Agency and Grant Number
Corresponding Author	Miguel Jiménez-Pérez, MD, Liver Transplantation and Hepatology Unit, UGC de Aparato Digestivo Hospital Regional Universitario, Avenida Carlos Haya, 29010 Malaga, Spain. mjimenezp@commalaga.com
Key Words	Hepatitis B virus; Liver transplantation; Recurrence; Prophylaxis; Hepatitis B immunoglobulin
Core Tip	The current success of liver transplantation in patients with chronic hepatitis B (CHB)-related cirrhosis is mainly due to the use of prophylaxis with hepatitis B immunoglobulins (HBIG) and oral antivirals against post-liver transplant recurrence of CHB. The combination of low-dose HBIG plus antivirals forms the current standard prophylaxis. The use of newer antivirals (entecavir and tenofovir), coupled with better understanding of the predisposing factors for recurrence of CHB, has led to new perspectives for prophylaxis regimens, aimed at withdrawal of HBIG or the use of HBIG-free regimens, oriented toward a strategy of individualized prophylaxis.
Publish Date	2015-11-11 13:34
Citation	Jiménez-Pérez M, González-Grande R, Mostazo Torres J, González Arjona C, Rando-Muñoz FJ. Management of hepatitis B virus infection after liver transplantation. World J Gastroenterol 2015; 21(42): 12083-12090
URL	http://www.wjgnet.com/1007-9327/full/v21/i42/12083.htm
DOI	http://dx.doi.org/10.3748/wjg.v21.i42.12083

Full Article (PDF)	WJG-21-12083.pdf
Full Article (Word)	WJG-21-12083.doc
Manuscript File	18384-Review.docx
Answering Reviewers	18384-Answering reviewers.pdf
Audio Core Tip	18384-Audio core tip.aiff
Conflict-of-Interest Disclosure Form	18384-Conflict-of-interest statement.pdf
Copyright License Agreement	18384-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	18384-Language certificate.pdf
Peer-review Report	18384-Peer-review(s).pdf
Scientific Misconduct Check	18384-Scientific misconduct check.pdf
Scientific Editor Work List	18384-Scientific editor work list.pdf